Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indicia is a French biotechnology company and Contract Development and Manufacturing Organization (CDMO) specializing in the production of high-quality reagents and media for microbiology and immunology. The company provides a wide range of products and services, including the manufacturing of ready-to-use culture media, clinical diagnostic kits, and industrial microbiology solutions for the pharmaceutical, cosmetic, and food industries. Indicia operates multiple production sites in France, offering custom formulation and filling services under strict quality standards. Their expertise spans from the development of innovative diagnostic tools to the large-scale production of biological reagents, supporting both clinical research and industrial quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indicia.